Assoc. Prof. Dr. Ozra Tabatabaei-Malazy | Medicine | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Ozra Tabatabaei-Malazy | Medicine | Best Researcher Award

Assoc. Prof. Dr. Ozra Tabatabaei-Malazy, Tehran University of Medical Sciences, Iran.

Dr. Ozra Tabatabaei Malazy is a distinguished researcher and academic in endocrinology and metabolism, associated with the Tehran University of Medical Sciences (TUMS) Endocrinology & Metabolism Research Institute (EMRI). Born in Iran in 1966, Dr. Tabatabaei has dedicated her career to improving clinical and public health outcomes, particularly in diabetes and metabolic disorders. With an impressive h-index of 23 (Scopus) and 33 (Google Scholar), she has contributed significantly to scientific knowledge through her expertise in clinical trials, cross-sectional studies, and meta-analyses. Her academic achievements include an MD, MPH, and PhD in Pharmacology, culminating in her current position as Assistant Professor. Dr. Tabatabaei’s influence extends to editorial roles in prominent journals, reflecting her commitment to advancing research quality and ethics. Her work is characterized by a focus on translating research into effective treatments and preventive measures, particularly for non-communicable diseases prevalent in Iran and worldwide.

Professional Profile

scopus

orcid

google scholar

summary of suitability for Best Researcher Award

Dr. Ozra Tabatabaei Malazy demonstrates an impressive track record in medical research, particularly in endocrinology and metabolism. Her extensive educational background, including an MD, an MPH focused on Knowledge Transfer Exchange, and a PhD in Pharmacology, aligns well with the research and clinical demands of the field. With over two decades of dedicated research experience at Tehran University of Medical Sciences, she has contributed to numerous studies on topics like diabetes, metabolic disorders, oxidative stress, and systematic reviews of therapeutic interventions. Her ongoing involvement in research projects, particularly in clinical trials, cross-sectional studies, and meta-analyses, highlights her commitment to advancing scientific knowledge and clinical practices.

🎓 Education 

Dr. Tabatabaei Malazy’s educational background underscores her dedication to both medical practice and research. She earned her General Medical Doctor (MD) degree in 1993, providing a strong foundation in clinical medicine. In 2006, she pursued a Master of Public Health (MPH) at Tehran University of Medical Sciences (TUMS), where her dissertation focused on Knowledge Transfer Exchange (KTE), a critical area for implementing research findings into healthcare practice. Driven by her passion for pharmacology and therapeutic interventions, she further advanced her academic qualifications with a PhD in Pharmacology in 2016. These degrees equipped her with the skills to integrate clinical insights with a population health perspective, fostering her development as a versatile researcher. Today, as an Assistant Professor, Dr. Tabatabaei combines her expertise in medicine, public health, and pharmacology to contribute to the fields of endocrinology and metabolism through her research and clinical trials.

💼    Experience 

Dr. Tabatabaei has a robust career in endocrinology and metabolism, with over two decades at the Tehran University of Medical Sciences’ Endocrinology & Metabolism Research Institute (EMRI). Since 1998, she has served as a research fellow, contributing to groundbreaking research in diabetes and lipid disorders. Additionally, she has been an active reviewer for journals like Iranian Journal of Diabetes & Lipid Disorders and Plos One, among others. Her influence extends to editorial roles, including Section Editor for the Journal of Diabetes and Metabolic Disorders and Plos One. Dr. Tabatabaei’s contributions are enriched by her membership on EMRI’s peer-review committee and her involvement as a guest editor. These positions showcase her commitment to advancing scientific standards. Through her editorial and peer-review work, Dr. Tabatabaei is shaping the quality of research published in her field, ensuring its relevance and integrity in endocrinology and metabolic sciences.

🏅Awards and Honors 

Dr. Tabatabaei’s outstanding contributions to endocrinology and metabolism have earned her numerous awards and honors, recognizing her influence in clinical research. Her editorial appointments across renowned journals such as Plos One and the Journal of Diabetes and Metabolic Disorders underline her authority in the field. Additionally, Dr. Tabatabaei’s role as a guest editor for Frontiers in Endocrinology highlights her expertise and leadership in metabolic research. Her efforts in reviewing and overseeing high-impact research have further contributed to her esteemed status within the academic community. With her impressive h-index metrics—23 in Scopus and 33 in Google Scholar—she is well-regarded for her scholarly impact. Dr. Tabatabaei’s recognitions underscore her commitment to advancing research and influencing global health perspectives, particularly within endocrinology and non-communicable disease prevention.

🌍   Research Focus 

Dr. Tabatabaei’s research primarily centers on non-communicable diseases, particularly diabetes and metabolic disorders. Her studies explore the underlying mechanisms of these conditions, emphasizing risk factors, preventive measures, and therapeutic interventions. Dr. Tabatabaei has contributed to numerous clinical trials and cross-sectional studies, providing valuable insights into the epidemiology and management of metabolic diseases. Her work often includes systematic reviews and meta-analyses, establishing her as a pivotal figure in evidence-based medicine. Dr. Tabatabaei is also actively involved in scientometric studies that analyze research trends and their impact on healthcare practices. Her commitment to research extends to the field of pharmacology, where she examines the effects of natural and synthetic compounds on metabolic health. Through her extensive research, Dr. Tabatabaei aims to develop practical solutions for managing and mitigating the global burden of diabetes and related metabolic disorders.

📖 Publication Top Notes

  • Title: Nurses’ role in diabetic foot prevention and care; a review
    Citation: 259
  • Title: New horizons in treatment of osteoporosis
    Citation: 211
  • Title: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …
    Citation: 185
  • Title: Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …
    Citation: 161
  • Title: Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease .
    Citation: 149

Dr. Guanhu Yang | Acupuncture | Research Excellence Award

Posted on by sciencefather

Dr. Guanhu Yang | Acupuncture | Research Excellence Award

Dr. Guanhu Yang, Ohio University, United States

Dr. Guanhu Yang, MD, PhD, LAc, is a distinguished figure in Traditional Chinese Medicine (TCM) with extensive experience spanning over three decades in both clinical practice and academia. Based in Mason, Ohio, he holds a PhD from Kanazawa Medical University in Japan, focusing on lung injury and repair. He also earned an MS from Nanjing University of Chinese Medicine and a medical degree from Zhejiang Chinese Medical University. Dr. Yang serves as a professor and doctoral supervisor and holds editorial roles in international medical journals. As the President of the Chinese Medicine Luobing Society of America and an executive leader in numerous TCM associations globally, Dr. Yang is dedicated to advancing integrative medicine. His clinical expertise and research contributions in TCM, particularly in acupuncture and herbology, continue to shape modern understanding of holistic healthcare.

Professional Profile

google scholar

Summary of Suitability for the Research for Research Excellence Award

Dr. Guanhu Yang, with his MD and PhD background in Traditional Chinese Medicine (TCM) and a substantial focus on lung injury and repair, presents a commendable profile for the “Research for Research Excellence Award.” His career spans more than three decades across multiple countries, including China, Japan, Canada, Switzerland, and the United States, where he has contributed as a clinician, academician, researcher, and leader. Dr. Yang has held diverse positions, such as a Clinical Professor, Editor, and President of TCM societies, and he actively shapes global standards in acupuncture and TCM practices. His experience extends to editing roles in prominent scientific journals, further demonstrating his impact on academic and clinical research communities. Moreover, his leadership in major TCM organizations and contribution to Chinese medicine education worldwide underscores his dedication to advancing medical science.

🎓    Education

Dr. Yang’s academic journey began at Zhejiang Chinese Medical University, where he earned his MD in Traditional Chinese Medicine. He furthered his studies at Nanjing University of Chinese Medicine, completing a master’s degree in Medical Science. His dedication to medical research led him to Kanazawa Medical University in Japan, where he earned a PhD focusing on lung injury and repair. Through his academic progression, Dr. Yang gained a strong foundation in traditional and modern medicine, enabling a profound understanding of integrative health practices. His extensive licensure includes certifications in Acupuncture and Oriental Medicine by the State Medical Board of Ohio, and he holds a Diplomate in both Acupuncture and Chinese Herbology from the NCCAOM, solidifying his credentials in Traditional Chinese Medicine and allowing him to practice and teach extensively across continents.

💼  Experience

Dr. Yang has held numerous positions worldwide, including Professor and Doctoral Supervisor at Macau University of Science and Technology and Clinical Professor at Ohio University. He serves as a guest editor for multiple scientific journals and holds visiting professor roles in Canada and the United States. He has worked extensively with global organizations such as the World Federation of Chinese Medicine Societies, serving as Vice Chairman on committees for both Endocrine and Digestion research. As the Chief Acupuncturist and owner of Acupuncture Wellness Center of Cincinnati and Mason, Dr. Yang combines his clinical expertise with research initiatives, significantly impacting both patient care and academic communities.

🏅  Awards and Honors

Dr. Yang’s dedication to Traditional Chinese Medicine has earned him numerous accolades, including the title of Distinguished Clinical Expert by the Swiss University of Traditional Chinese Medicine. He has been recognized for his editorial contributions as Associate Editor for leading journals, including the New England Journal of Traditional Chinese Medicine. His influence extends to various TCM associations, serving as Vice President of the American TCM Association and American Association of Chinese Herbs. Dr. Yang’s contributions to integrative medicine and his role as an academic advisor to international institutes underscore his impact and dedication to advancing Traditional Chinese Medicine.

🌍  Research Focus

Dr. Yang’s research integrates Traditional Chinese Medicine with modern medical sciences, focusing on the effects of acupuncture and herbal medicine on chronic diseases, including lung injury, endocrinology, and internal medicine. His studies in gene therapy and cancer drug targeting have led to numerous publications in high-impact journals. He is particularly interested in the dose-response relationship within herbal prescriptions, aiming to enhance the efficacy of TCM treatments. As a research scientist and clinical professor, Dr. Yang continues to advance therapeutic interventions that bridge Eastern and Western practices, fostering a holistic approach to healthcare.

📖 Publication Top Notes

  • Title: The transcription factor gene Nfib is essential for both lung maturation and brain development

    Cited by: 349

  • Title: Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia

    Cited by: 121

  • Title: The most commonly treated acupuncture indications in the United States: a cross-sectional study

    Cited by: 102

  • Title: Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription

    Cited by: 81

  • Title: Schaftoside ameliorates oxygen glucose deprivation-induced inflammation associated with the TLR4/Myd88/Drp1-related mitochondrial fission in BV2 microglia cells

    Cited by: 67

Assist. Prof. Dr. Ebtesam Yousef | Ostracoda | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Ebtesam Yousef | Ostracoda | Best Researcher Award

Assist. Prof. Dr. Ebtesam Yousef, Assistant Professor of Faculty of Science, Egypt

Ebtesam Ahmed Yousef Abd elhaleem is an Assistant Professor at the Zoology Department, Faculty of Science, Sohag University, Egypt. Born on December 26, 1974, in Sohag, Egypt, she has made significant contributions to the field of invertebrate zoology, particularly marine ostracods. With an extensive background in taxonomy and biological studies, she has published numerous research papers on the biodiversity and ecology of marine species in the Red Sea. Fluent in Arabic, English, and German, she brings a diverse set of skills, including expertise in Microsoft Office, Photoshop, and statistical software like SPSS. She is committed to advancing zoological research and educating future generations of scientists.

Professional Profile

Scopus

Summary of Suitability for the Research for Best Researcher Award

Dr. Ebtesam Ahmed Yousef Abd elhaleem is a strong candidate for the ‘Research for Best Researcher Award.’ Her extensive research on ostracods, contributions to marine biodiversity, and commitment to academic excellence through teaching and journal refereeing make her highly suitable for the award. Her work aligns with the objectives of the award, recognizing researchers who contribute significantly to their field while promoting academic growth and innovation.

🎓 Education

Ebtesam completed her undergraduate degree in Zoology at Sohag Faculty of Science, Assiut University in 1996. She then progressed to obtain her Master’s degree in 2003, focusing on taxonomic and morphological studies of marine ostracods from the Red Sea. Her Ph.D., awarded by Sohag University in 2008, expanded on these studies, delving deeper into the biological traits of ostracod species from the Red Sea. Her research contributed significantly to the understanding of marine biodiversity and invertebrate taxonomy. Ebtesam’s expertise in zoology, particularly in studying ostracods, has positioned her as a key academic in this field.

💼 Experience 

Ebtesam has a broad academic career, starting as a demonstrator in 1997 before moving into research and teaching roles. She has been an Assistant Professor at Sohag University since 2018, where she teaches undergraduate and postgraduate courses, including invertebrate taxonomy, vertebrate anatomy, and general physiology. Her research focuses on marine crustaceans, specifically ostracods, contributing new knowledge on species diversity in Egypt’s Red Sea. Additionally, Ebtesam is a peer reviewer for several scientific journals, such as Invertebrate Reproduction & Development Journal and BMC Zoology Journal. Her teaching and research excellence continue to inspire her students and peers.

🏅Awards and Honors 

Ebtesam has received numerous accolades for her academic contributions. Among her most notable achievements is her promotion to Assistant Professor in 2018, reflecting her strong academic standing and dedication to zoological research. She has also been recognized for her scientific papers on the taxonomy and biology of marine ostracods, with several of her publications being featured in high-impact journals. Ebtesam’s research has not only garnered respect within academic circles but has also contributed to the greater understanding of marine biodiversity in the Red Sea region.

🌍 Research Focus 

Ebtesam’s research primarily revolves around marine biodiversity, focusing on the taxonomy and ecology of ostracods, a group of small crustaceans found in marine environments. Her studies on the Red Sea ostracods have provided new insights into species diversity, ecological roles, and adaptation to marine habitats. She is particularly interested in how environmental factors affect ostracod populations and their ecological significance. Through her research, she aims to contribute to global conservation efforts by highlighting the importance of marine ecosystems in Egypt and beyond.

📖 Publication Top Notes

Effect of Environmental Variables on Zooplankton in Various Habitats of the Nile River
Citation: 1
Therapeutic efficacy of geranium-thymol combination against murine eimeriosis with reference to its apoptotic activity
Morphology and molecular identification of Heterocypris incongruens female from AlUla, Kingdom of Saudi Arabia
Morphological re-Description and molecular characterization of heterocypris salina (Brady, 1868), A new recorded ostracod species in Egypt
Citation: 5
The ontogeny of appendages and carapace of Neonesidea schulzi (Ostracoda: Bairdiidae) from the Red Sea coast, Egypt
Citation: 1

Arnulf Stenzl | Health Professions | Academic Excellence Award

Posted on by sciencefather

Prof Dr Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl, Universität Tübingen, Tübingen Deutschland ,Germany

Prof. Dr. Arnulf Stenzl is an Austrian-born urologist and global leader in urological oncology. He received his medical degree from Karl-Franzens University in Graz, Austria, in 1980 and subsequently trained in surgery and urology across Austria, Switzerland, and the United States. Since 2002, he has headed the Department of Urology at Eberhard-Karls University in Tübingen, Germany, where he oversees critical research on urological cancers. Prof. Stenzl’s contributions extend internationally, with membership in numerous editorial boards and global collaborations. He has played a pivotal role in shaping European urological policies as Secretary General of the European Association of Urology. His work has led to several groundbreaking patents in the field, furthering innovations in patient care.

Professional Profile

Education 

Prof. Dr. Arnulf Stenzl embarked on his academic journey in 1973 when he enrolled at Karl-Franzens University in Graz, Austria, where he earned his Doctor medicinae universalis (M.D.) in February 1980. His initial training spanned internal medicine, nephrology, and pathology at Landeskrankenhaus Klagenfurt and Karl-Franzens University. From 1984 to 1987, he undertook specialized training in urology, first at Karl-Franzens University, then further expanding his knowledge as a fellow in general urology and urologic oncology at the University of California, Los Angeles (UCLA). His education, which encompassed diverse fields such as trauma, vascular, and plastic surgery, provided him with a holistic understanding of medicine and surgery. His dedication to learning has been reflected in his ongoing research and innovative contributions to urology.

Experience 

Prof. Dr. Arnulf Stenzl has had a distinguished career spanning over three decades. After serving as an assistant professor at the University of Bern in Switzerland, he moved to the University of Innsbruck, Austria, where he eventually became vice-chairman of the Department of Urology. Since 2002, he has led the Department of Urology at Eberhard-Karls University Tübingen, Germany, overseeing the clinical, academic, and research arms of the institution. Prof. Stenzl has driven numerous groundbreaking research projects, collaborating with both academic and industrial partners. As Secretary General of the European Association of Urology, he has led European urological research and development initiatives. His expertise extends to cancer research, with numerous contributions to advancing treatment modalities for bladder and prostate cancer.

Awards and Honors 

Prof. Dr. Arnulf Stenzl’s career is marked by numerous prestigious awards and honors. He is an honorary member of several international urological societies, including the Bristol Urological Institute and the Canadian Urological Association. His service as President of the German Urological Association (2020-2021) highlights his leadership within the field. Additionally, his involvement as Chairman of the Scientific Congress Office for the European Association of Urology and his role on the Board of Directors of the European CanCer Organisation demonstrate his commitment to global urological advancement. Prof. Stenzl’s contributions to scientific literature have earned him multiple editorial board memberships. His innovative spirit is further evidenced by several patents, including implantable devices to treat urinary incontinence and risk prediction models for renal cell carcinoma.

Research Focus 

Prof. Dr. Arnulf Stenzl’s research is at the forefront of urological oncology, focusing on advanced treatment modalities for bladder and prostate cancers. His work delves into personalized cancer therapies, optimizing clinical outcomes through precision medicine approaches. A significant aspect of his research revolves around biomarker discovery and risk stratification, which aim to enhance early diagnosis and targeted treatment. He has contributed to pioneering studies in immunotherapy, including innovative techniques for bladder cancer surgery and the integration of novel hormonal therapies in prostate cancer treatment. Prof. Stenzl is also involved in collaborative research projects with industry, furthering the development of next-generation urological treatments. His innovative contributions have resulted in several patents, solidifying his standing as a leader in urological research and technology.

Publications top notes

  • Treatment Intensification With Novel Hormonal Therapy in Prostate Cancer 📚🧪
  • Sacituzumab Govitecan Efficacy in Urothelial Cancer 🧬🔬
  • Co-occurring BRCA2/SPOP Mutations and PARP Inhibitor Sensitivity 🧬⚕️
  • Epacadostat Plus Pembrolizumab for Urothelial Carcinoma 💉🧪
  • Impact of Teratoma on Survival in Germ Cell Cancer 🧫🩺
  • Sacituzumab Govitecan & Pembrolizumab in Urothelial Cancer 💊🧪
  • TROPHY-U-01 Study on Sacituzumab Govitecan in Metastatic Urothelial Cancer 🧬🔬
  • Efficacy of Darolutamide in Black Patients With Prostate Cancer ⚕️🩺
  • Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer 🧬💉